News in the Life Sciences Industry

STOCKHOLM, Nov. 25, 2019 /PRNewswire/ -- Cantargia AB (publ) hereby provides notification that the Nomination Committee has been appointed ahead of the 2020 Annual General Meeting, and consists of Sten Verland (partner at Sunstone Life Science Ventures), Jannis Kitsakis (Fjärde AP-fonden),... Read more ››

STOCKHOLM, Nov. 21, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company has signed an agreement with a UK contract research organization (CRO) to conduct the six-month toxicology studies with Rabeximod as required ahead of the Phase... Read more ››

STOCKHOLM, Nov. 21, 2019 /PRNewswire/ -- VeliMark Oy, OptiGroup's Finnish company within the Facility, Safety & Foodservice business area, today announces the acquisition of Walki Medical Oy. Walki Medical is one of Finland's largest distributors of medical supplies with a turnover of EUR... Read more ››

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Today, hygiene and health company Essity continues its commitment to breaking barriers to well-being by convening the United Nations Foundation's annual Global Dialogue on the Sustainable Development Goals (SDGs). These were adopted by the United Nations... Read more ››

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Biovica, active in cancer biomarkers, today announced that clinical data - demonstrating that DiviTum can be used as a dynamic, non-invasive biomarker for metastatic breast cancer patients treated with endocrine therapy and palbociclib - will be presented... Read more ››

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ --

HUDDINGE, Sweden, Nov. 20, 2019 /PRNewswire/ -- On November 5, 2019, Karo Pharma Aktiebolag ("Karo Pharma") issued a press release regarding the Pfizer collaboration and license agreement related to ROR-gamma ("the Pfizer agreement"). The press release informed of Pfizer's decision to terminate... Read more ››

STOCKHOLM, Nov. 19, 2019 /PRNewswire/ -- OssDsign CEO Anders Lundqvist: "To conclude it has been a busy and rewarding quarter which has seen the positive effects of the important investments in the US organization and transition of the business to OssDsign USA Inc."

LUND, Sweden, Nov. 19, 2019 /PRNewswire/ -- Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on May 22, 2019 and has the following composition:

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) reports today that the ninth and final patient was recruited to the phase Ia study of MIV-818 in patients with advanced liver cancer. Based on data from phase Ia, the initial dose of MIV-818 for the phase Ib... Read more ››

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Scandinavian ChemoTech and its CEO Mohan Frick has been selected to present its Tumour Specific Electroporation at the Emerging Medtech Summit in California, USA. An event bringing together the top strategists, investors, and innovators within the... Read more ››